Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma

BACKGROUND: The prevalence of non‐B or non‐C hepatocellular carcinoma (NBNC‐HCC) has been increasing all over the world. Advanced glycation end products (AGE) play a role in the pathogenesis of alcoholic liver injury or nonalcoholic steatohepatitis (NASH). METHODS: We examined here whether serum lev...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Lab Anal
Auteurs principaux: Kan, Hiromi, Yamagishi, Sho‐ichi, Ojima, Ayako, Fukami, Kei, Ueda, Seiji, Takeuchi, Masayoshi, Hyogo, Hideyuki, Aikata, Hiroshi, Chayama, Kazuaki
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2014
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807017/
https://ncbi.nlm.nih.gov/pubmed/25252033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21797
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires